EDITORIAL SYNOPSIS Extracts of duodenal mucosa containing cholecystokinin and pancreozymin inhibited gastric motility completely in eight subjects whereas secretin extracts produced variable results. It is suggested that cholecystokinin-pancreozymin extracts may contain enterogastrone.
The inhibition of gastric motility induced by placing fat in the duodenum was demonstrated to be humoral by Farrell and Ivy (1926) . Subsequent studies on extracts of duodenal mucosa have failed to define the substance involved, although the concept that 'enterogastrone' is a duodenal hormone inhibiting both gastric motility and acid secretion is accepted (Grossman, 1950) .
In recent years, specific extracts of duodenal mucosa containing cholecystokinin, secretin, and pancreozymin activity (Jorpes and Mutt, 1959) have been prepared. One of these preparations containing secretin was found to inhibit gastric acid secretion (Greenlee, Longhi, Guerrero, Nelsen, El Bedri, and Dragstedt, 1957) . This work was later confirmed with the improved duodenal extracts currently available (Wormsley and Grossman, 1964) . Recently extracts containing cholecystokinin-pancreozymin activity were also found to inhibit gastric acid secretion and to exceed secretin preparations in potency (Gillespie and Grossman, 1964; Jordan and De la Rosa, 1965) .
In the study of duodenal extracts and their relation to gastric motor activity, it is noteworthy that one of the first preparations used to duplicate the action of fat in the duodenum was an extract containing cholecystokinetic activity (Kosaka and Lim, 1930) . Current studies in this laboratory have demonstrated gastric motor inhibition in denervated fundic pouches and innervated stomachs of dogs by intravenous infusions of a cholecystokinin-pancreozymin preparation (Johnson and Magee, 1965 ascribed to enterogastrone and duplicates the action of fat in the duodenum.
The present study tests the effect of two extracts of duodenal mucosa, one containing secretin and the other cholecystokinin-pancreozymin, on gastric motor activity in man.
METHODS
The study was performed on eight subjects, seven males and one female, between the ages of 20 and 28. All tests were made after an overnight fast. A condom balloon fixed to a plastic levine tube (16F) was passed into the stomach and inflated with 400 ml. of air. The tube was then connected to a water-filled, low-pressure Statham transducer. Pressure changes were monitored by a penwriting recorder, the subject lying quietly in the supine position. A slow intravenous infusion of 5% glucose solution was started in the forearm and continued throughout the experiment. A constant-speed infusion pump was used to infuse the extracts slowly into the intravenous tubing, making it possible to give the preparations without the knowledge of the patient. This was considered important as almost any anxiety-producing stimulus was found to be capable of inhibiting gastric motor function in some subjects.
After a suitable basal recording, a secretin preparation3 (hereafter termed 'secretin') was infused over a 10-minute period at 0 05 unit/kg./min. to a total dose of 0 5 unit/kg. When gastric activity had returned to normal, a cholecystokinin-pancreozymin preparation (Cecekin4) was infused in exactly the same manner and dose. Again the motor activity was monitored until it returned to normal.
The eight subjects included in the study experienced no untoward effects from the procedure. Two volunteers were excluded as vomiting occurred in both, one during and the other shortly after, infusion of Cecekin.
The resulting gastric pressure tracings were analysed by comparing a 10-minute control period just before secretin infusion, a 10-minute period during maximum Effect of secretin and cholecystokinin-pancreozymin extracts on gastric motility in man inhibition by secretin or Cecekin, and a 10-minute period during maximum recovery of activity. Several measurements were utilized to compare activity within the three time periods, and these are defined as follows:
1 Changes in mean pressure express the difference in millimetres between the mean point of all waves in the control period with that during maximum inhibition. The mean is established as the mid-point between the highest peak and lowest point of relaxation during the period.
Pressure is expressed in millimetres measured from the tracing with each subject serving as his own control.
Actual intragastric pressures can be determined from the tracing using a conversion of 10 mm. = 6-4 cm. H20 pressure. The range of intragastric pressures varied from 0 to 48 cm. of water.
2 Latent period is the length of time from the onset of infusion to the beginning of inhibition measured in minutes.
3 Contraction frequency is the number of pressure waves per 10 minutes in the control and infusion periods compared.
4 Percentage activity is the percentage of time during the 10-minute period when pressure wave activity is seen.
5 Amplitude index is the summation of amplitudes of all the waves during the 10-minute period. Amplitudes are measured from the base of each contraction and thus 'amplitude index' expresses only wave height and not changes in baseline.
6 Duration of inhibition is the elapsed time from beginning inhibition to full recovery of activity.
RESULTS
Tracings from two experiments are shown in Figures 1 and 2 . The larger gastric pressure contractions can be clearly differentiated from the superimposed small respiratory waves. The motor inhibition due to infusion of Cecekin was a consistent response, whereas the effect of secretin varied from subject to subject as demonstrated in these two tracings. The results of the studies are discussed below.
MEAN PRESSURE Secretin produced an initial increase in mean pressure in five of eight subjects. This was followed in four of the five by a decrease in pressure after a latent period of several minutes. Cecekin always produced a prompt reduction in mean (Fig. 3) LATENT PERIOD The latent period for inhibition following secretin infusions extended up to 10 minutes, with a mean of over six minutes in the cases in which activity was inhibited. By contrast, the latent period following Cecekin averaged less than two minutes (Fig. 4) . CONTRACTION 
FREQUENCY Following secretin
injections, the number of gastric pressure contractions per 10-minute period decreased in five subjects. The mean frequency reduction for the eight subjects was not significant. By contrast frequency was reduced in each instance after Cecekin (Fig. 5) (Fig. 6) .
AMPLITUDE INDEX Six of the eight tests with the secretin preparation demonstrated some reduction of amplitude index. However, the mean decrease was of borderline significance. Decreases occurred in each of the studies following Cecekin with a significant mean reduction in amplitude index for the entire group (Fig. 7) (Hong, Magee, and Crewdson, 1956 ). The secretin was injected intravenously in doses slightly exceeding 05 unit/kg. None of the extracts produced a rise in intracholecystic pressure. By contrast, Cecekin consistently produced gall-bladder contraction in this animal in doses as low as 0*l unit/kg. It is concluded that the partial gastric motor inhibition produced by secretin in man cannot be explained by the presence of cholecystokinin activity in the material.
Whether the variation in response to secretin preparations was due to differences in the material (all vials used were from the same batch) or to differences in individual responsiveness, was tested in the following manner:-One of the subjects, D.H., was noted to have rather marked inhibition following secretin. The next subject, J.A., showed very slight inhibition with secretin. The preparation which had previously caused marked inhibition of motor activity in D.H. was infused into J.A., producing only slight inhibition. This suggests individual differences rather than variation in the secretin preparation.
DISCUSSION
In man, the reduction of gastric motor activity following secretin extracts is not a consistent response, nor is the duration of inhibition comparable to that produced by the cholecystokininpancreozymin material. The induced secretin inhibition also differs from Cecekin in its comparatively long latent period. The prompt inhibition by Cecekin suggests a direct action on the gastric smooth muscle. The initial increase in contractile activity in some subjects, followed in several minutes by a reduction in motility, may represent an indirect effect in the case of secretin. Perhaps it acts secondarily by changing the content and pH of the duodenum through secretion of alkaline pancreatic juice. At present the mode of action of these extracts on gastric motor activity is unknown.
The consistent gastric motor inhibition in man, produced by extracts containing both cholecystokinetic and pancreozymin activity, parallels that seen in the dog. Similar preparations have been found to inhibit gastric acid secreted in response to all types of acid stimuli (Gillespie and Grossman, 1964; Jordan and De la Rosa, 1965 ). This material is thus capable of reproducing the action of fat in the duodenum, as measured by gastric motor and secretory activity. Because it possesses the physiological activity ascribed to enterogastrone, perhaps this preparation contains the true gastric chalone of duodenal origin. It may be that the same hormones
